Evotec SE Financials
| EVT Stock | 8.41 0.01 0.12% |
Evotec |
Understanding current and past Evotec SE Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Evotec SE's financial statements are interrelated, with each one affecting the others. For example, an increase in Evotec SE's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Evotec SE's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evotec SE. Check Evotec SE's Beneish M Score to see the likelihood of Evotec SE's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | XETRA Stock Exchange |
| ISIN | DE0005664809 |
| Business Address | Essener Bogen 7, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.evotec.com |
| Phone | 49 40 560 81 0 |
You should never invest in Evotec SE without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evotec Stock, because this is throwing your money away. Analyzing the key information contained in Evotec SE's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Evotec SE Key Financial Ratios
Evotec SE's financial ratios allow both analysts and investors to convert raw data from Evotec SE's financial statements into concise, actionable information that can be used to evaluate the performance of Evotec SE over time and compare it to other companies across industries.| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 | |||
| Target Price | 27.1 | |||
| Beta | 1.01 | |||
| Z Score | 3.6 |
Evotec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evotec SE's current stock value. Our valuation model uses many indicators to compare Evotec SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evotec SE competition to find correlations between indicators driving Evotec SE's intrinsic value. More Info.Evotec SE is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evotec SE's earnings, one of the primary drivers of an investment's value.Evotec SE Systematic Risk
Evotec SE's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evotec SE volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Evotec SE correlated with the market. If Beta is less than 0 Evotec SE generally moves in the opposite direction as compared to the market. If Evotec SE Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evotec SE is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evotec SE is generally in the same direction as the market. If Beta > 1 Evotec SE moves generally in the same direction as, but more than the movement of the benchmark.
Evotec SE December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evotec SE help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evotec SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evotec SE based on widely used predictive technical indicators. In general, we focus on analyzing Evotec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evotec SE's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.67 | |||
| Information Ratio | 0.1173 | |||
| Maximum Drawdown | 36.91 | |||
| Value At Risk | (8.38) | |||
| Potential Upside | 9.76 |
Additional Tools for Evotec Stock Analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.